MedPath

Tear Osmolarity Clinical Utility in Dry Eye Disease

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Other: Saline
Other: Tear supplement
Other: Tear supplement 2
Dietary Supplement: Omega 3 nutrition supplement
Device: Eye bag
Registration Number
NCT02417116
Lead Sponsor
Aston University
Brief Summary

Millions of people suffer from dry eye disease, causing symptoms such as redness, burning, feeling of sand or grit in the eye and light sensitivity. Dry eye disease occurs when your eyes do not produce enough tears or produce poor quality tears. This can happen for a number of reasons, including aging, hormonal changes in women and side effects of diseases or medications.

It is now possible to objectively measure the degree of dry eye disease by collecting a tiny sample of tears from the corner of the eye and then measuring the amount of salt in the tears (termed osmolarity). We aim to establish the overall levels of raised and normal tear osmolarity in people presenting to the eye clinic with complaints of dry eye, and relate this to other factors such as symptoms, topical and nutritional medication and dry eye treatment.

Detailed Description

This study will investigate the efficacy of two treatment non-pharmaceutical therapies (tear drop alone, tear drop combined with omega 3 nutritional supplement and warm compresses) for dry eye reporting patients against a control (saline) over a 3 month period. A relatively new clinical measure (osmolarity) will be performed alongside traditional tear film volume, tear film stability, gland integrity and ocular surface damage measures to determine how this influences symptomatic complaints.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Dry Eye Symptoms SPEED >8
Read More
Exclusion Criteria
  • Unable to participate in 90 days therapy
  • Allergic to therapy
  • On medication known to affect ocular surface / tear film
  • Had ocular trauma, infection or surgery
  • Diagnosed with a medical condition known to affect ocular surface / tear film
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlSalineMinims Saline (Preservative Free) lubricant eye drops - daily for 90 days
Hypromellose - standard treatmentTear supplementTear Supplement: Hypromellose 0.3% eye drops - daily for 90 days
Combination treatmentEye bagTear Supplement 2: Hylo-Forte 0.2% Sodium Hyaluronate eye drops, Omega 3 nutrition supplement: Omega-3 tablets, Eye bag: TranquilEyes Moist Heat Lid Compresses - Daily for 90 days;
Combination treatmentOmega 3 nutrition supplementTear Supplement 2: Hylo-Forte 0.2% Sodium Hyaluronate eye drops, Omega 3 nutrition supplement: Omega-3 tablets, Eye bag: TranquilEyes Moist Heat Lid Compresses - Daily for 90 days;
Combination treatmentTear supplement 2Tear Supplement 2: Hylo-Forte 0.2% Sodium Hyaluronate eye drops, Omega 3 nutrition supplement: Omega-3 tablets, Eye bag: TranquilEyes Moist Heat Lid Compresses - Daily for 90 days;
Primary Outcome Measures
NameTimeMethod
Osmolarity change3 months

Salt balance in tears measured with the Tearlab

Secondary Outcome Measures
NameTimeMethod
Tear break-up time change3 months

Tear stability following a blink

Corneal staining change3 months

Fluorescein dye applied to the ocular surface and observed with blue light and a yellow filter to observe staining fluorescence

Tear Meniscus Height3 months

Height of tear meniscus along the lower lid margin observed through a slit-lamp microscope

SPEED Questionnaire change3 months

Dry eye symptomology questionnaire

Meibomian gland change3 months

Grading of meibomian glands using Oxford scale

Trial Locations

Locations (2)

Black & Lizars Optometrists

🇬🇧

Glasgow, United Kingdom

Robert Frith Opticians

🇬🇧

Twickenham, Middlesex, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath